Outcomes of lobectomy on pulmonary function for early stage non-small cell lung cancer (NSCLC) patients with chronic obstructive pulmonary disease (COPD).
Sen WeiFeng ChenRenwang LiuDianxun FuYanye WangBo ZhangDian RenFan RenZuoqing SongJun ChenSong XuPublished in: Thoracic cancer (2020)
A short-term (3-6 months) loss of pulmonary function after operation is acceptable for lung cancer patients with COPD. However, there may be a high risk of postoperative complications in NSCLC patients with COPD. Therefore, surgical treatment needs to be carefully considered for these patients.
Keyphrases
- chronic obstructive pulmonary disease
- early stage
- lung function
- small cell lung cancer
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- advanced non small cell lung cancer
- prognostic factors
- peritoneal dialysis
- cystic fibrosis
- radiation therapy
- type diabetes
- metabolic syndrome
- squamous cell carcinoma
- adipose tissue
- epidermal growth factor receptor
- tyrosine kinase
- glycemic control